African women living with HIV have an effective option to prevent malaria during pregnancy, clinical trial finds

In women living with HIV, preventive treatment with DHA-PPQ is a safe and effective strategy to prevent malaria during pregnancy, according to the final results of MAMAH, a clinical trial coordinated by the Barcelona Institute for Global Health (ISGlobal). The study, published in the Lancet Infectious Diseases, could help protect the health of the estimated one million pregnant women who suffer from a double infection with malaria and HIV every year.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart